Johnson & Johnson executives expect to release data on the efficacy of its coronavirus vaccine by early next week. It sets the stage to apply for emergency use authorization from the U.S. Food and Drug Administration, a process that can take several weeks. The vaccine is highly anticipated because it only requires one dose and needs traditional refrigeration for storage. Both Pfizer and Moderna’s vaccines require two doses. Moderna’s demands freezer temperatures, while Pfizer’s needs ultra-cold storage. Both have presented logistical challenges for distribution.
Johnson & Johnson’s vaccine completed Phase III trials on 60,000 volunteers. U.C. San Diego partnered with the pharmaceutical company to help study roughly 2,000 San Diegans, including National City Mayor Alexandria Sotelo-Solis.
National City has the highest case rate of any incorporated city in San Diego County.
“We’re part of a bigger solution in stopping this pandemic,” she said during her final check-up of the trial. “If they get the thumbs up, which we’re hoping for, this will be another option for our community.”
Read the full story here: [ Ссылка ]
